Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

被引：0
|
作者：
Al-Samkari, Hanny [1 ]
Kuter, David J. [2 ]
机构：
[1] Harvard Univ, Dana Farber Canc Inst, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117267
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
734
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [2] Thrombopoietin Level Predicts Response to Treatment with Romiplostim in Chemotherapy-Induced Thrombocytopenia
    Song, Andrew B.
    Goodarzi, Katayoon
    Leaf, Rebecca Karp
    Kuter, David J.
    Al-Samkari, Hanny
    [J]. BLOOD, 2021, 138
  • [3] Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia
    Song, Andrew B.
    Goodarzi, Katayoon
    Leaf, Rebecca Karp
    Kuter, David J.
    Al-Samkari, Hanny
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1563 - 1568
  • [4] Thrombopoietin Receptor Agonists Eltrombopag and romiplostim for the treatment of chronic immune thrombocytopenia purpura
    Atkinson, Katie
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (02) : 212 - 216
  • [5] Role of thrombopoietin stimulating agents (Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE
    Toro-Velez, Esteban
    Nova-Escobar, Santiago
    Jaramillo-Arroyave, Daniel
    [J]. IATREIA, 2021, 34 (03) : 253 - 259
  • [6] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [7] Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (02) : 168 - 168
  • [8] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Tomonori Nakazato
    Chisako Ito
    Ai Mihara
    Yoshinobu Aisa
    [J]. International Journal of Hematology, 2013, 97 : 291 - 293
  • [9] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Nakazato, Tomonori
    Ito, Chisako
    Mihara, Ai
    Aisa, Yoshinobu
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 291 - 293
  • [10] Cost-minimization analysis of immune thrombocytopenia treatment with romiplostim and eltrombopag
    Marzal Alfaro, M. B.
    Marquinez Alonso, I.
    Escudero Vilaplana, V.
    Pernia Lopez, S.
    Sanjurjo Saez, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 975 - 976
12345